| Publication Number | Title | Priority Date |
|---|---|---|
| CN-113444069-A | 2-aryl-4- (1H-pyrazol-3-yl) pyridine LSD1/HDAC double-target inhibitor | 2021-07-07 |
| CN-114014890-A | Compound with RIP2 kinase inhibitory activity, pharmaceutical composition containing same, and application thereof | 2021-03-12 |
| CN-113321645-A | 5-aminoisoxazole derivative and application thereof in preparation of multi-kinase inhibitor | 2021-01-07 |
| CN-112645878-A | N-containing compound with specific response to pressure stimulation, preparation method and application | 2020-12-14 |
| WO-2022017515-A1 | Diarylamine compound, preparation method therefor and application thereof | 2020-07-24 |
| WO-2022002243-A1 | Imidazopyrimidine derivative, preparation method therefor and medical use thereof | 2020-07-02 |
| WO-2021263278-A1 | Rev-erb agonists for the treatment of th17-mediated inflammatory disorders | 2020-06-23 |
| WO-2021244505-A1 | New pyrazine compound | 2020-06-01 |
| WO-2021233397-A1 | Piperazine cyclic ureas | 2020-05-20 |
| CN-113149996-A | Polycyclic amide derivative serving as CDK9 inhibitor, and preparation method and application thereof | 2020-05-12 |
| PMID | Publication Date | Title | Journal |
|---|---|---|---|
| 22917519 | 2012-09-15 | Inhibitor scaffold for the histone lysine demethylase KDM4C (JMJD2C) | Bioorganic & medicinal chemistry letters |
